Clinical trial · Interventional
The Effect of Cipralex on Quality of Life, Adrenal Activity Glucose Metabolism, Physical and Mental Health in PCOS
The Effect of Cipralex in Polycystic Ovary Syndrome
NCT01961180CI-TRIAL-00022058completedPhase 4ClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
Objectives: To investigate the effect of Cipralex versus placebo on stress hormones, glucose metabolism, physical and mental health and quality of life in polycystic ovary syndrome(PCOS). Treatment: 2x20 women for 12 weeks. Design: Double blinded, randomized, placebo controlled.
Conditions
Conditions (1)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Polycystic Ovary Syndrome | — | UNRESOLVED | — |
Interventions
Interventions (2)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| Cipralex | Drug | — | UNRESOLVED |
| Placebo | Drug | — | UNRESOLVED |
Design
Arms and outcomes
Arms (2)
- type
- ACTIVE_COMPARATOR
- label
- active comparator
- description
- Drug: Cipralex
- interventionNames
- Drug: Cipralex
- type
- PLACEBO_COMPARATOR
- label
- placebo comparator
- description
- Drug: Placebo
- interventionNames
- Drug: Placebo
Primary outcomes (1)
- measure
- Quality of Life
- timeFrame
- 14 weeks
- description
- Measured by questionaires
Eligibility
Eligibility (as posted)
- Sex
- Female
- Minimum age
- 18 Years
- Maximum age
- 50 Years
Show eligibility criteria text
Inclusion Criteria: * BMI \>25 and \<50 * Age \< 50 * PCOS Exclusion Criteria: * Epilepsia * use of metformin or oral anticonceptives * pregnancy/breastfeeding
References
Publications (0)
Data not yet available
No reference posted for this study.